Psoralens used for cosmetic sun tanning: an unusual cause of extensive burn injury.
Psoralen combined with long-wave ultraviolt radiation (UV-A) has become a standard method of psoriasis treatment. A well-known and often appreciated 'side-effect' is the hyperpigmentation caused by this treatment. Three patients demonstrating a novel cause of severe skin loss, 'psoralen burn', are presented. No patient was afflicted by psoriasis and all three had used psoralen and ultraviolet exposure with the intent to enhance sun tanning. In the case histories presented, it is notable that two of the patients share an alarmingly extensive skin injury (90-95 per cent body surface area), while the third had an extensive but rather superficial injury. In addition, a very similar time-table for the development of the injury could be observed, with a maximum distribution of skin loss not reached until 7 or 8 days after exposure. Psorelen-UV-A can cause life-threatening skin losses when used in an erratic manner. Early recognition of the nature and knowledge of the time-course in the development of these lesions is necessary for optimal treatment. Some principles of treatment are discussed. Dermatologists prescribing PUVA treatment should further increase their warnings of uncontrolled use of psoralens in non-psoriatrics.
Nettelblad
H
H
Department of Hand Surgery, Plastic Surgery and Burns, University Hospital, Linköping, Sweden.
Vahlqvist
C
C
Krysander
L
L
Sjöberg
F
F
D000328:Adult; D001768:Blister / Q000209:etiology; D001830:Body Surface Area; D002056:Burns / Q000209:etiology* / Q000473:pathology; D005260:Female; D011564:Furocoumarins / Q000009:adverse effects*; D006801:Humans; D009102:Multiple Organ Failure / Q000209:etiology; D011701:PUVA Therapy / Q000009:adverse effects; D017319:Photosensitizing Agents / Q000009:adverse effects*; D011565:Psoriasis / Q000188:drug therapy; D012880:Skin Pigmentation / Q000187:drug effects*; D013471:Sunburn / Q000209:etiology / Q000473:pathology; D013472:Sunlight / Q000009:adverse effects*
D011564:Furocoumarins; D017319:Photosensitizing Agents